4-tert-Octylphenol


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0006144 Purine nucleobase metabolic process Increases phenotype PMID:30487447
GO:0006541 Glutamine metabolic process Increases phenotype PMID:30487447
GO:0006805 Xenobiotic metabolic process Increases phenotype PMID:29162470
GO:0006909 Phagocytosis Decreases phenotype PMID:26133781
GO:0007283 Spermatogenesis Decreases phenotype PMID:29029336
GO:0007566 Embryo implantation Decreases phenotype PMID:30061528
GO:0008210 Estrogen metabolic process Affects phenotype PMID:28611354
GO:0008283 Cell population proliferation Increases phenotype PMID:23626723; PMID:24213142; PMID:24684733
GO:0008284 Positive regulation of cell population proliferation Increases phenotype PMID:29783106; PMID:29783106; PMID:35307500
GO:0008584 Male gonad development Affects phenotype PMID:28611354
GO:0030263 Apoptotic chromosome condensation Increases phenotype PMID:28611354; PMID:29029336
GO:0031589 Cell-substrate adhesion Decreases phenotype PMID:32466334
GO:0042816 Vitamin b6 metabolic process Increases phenotype PMID:30487447
GO:0044319 Wound healing, spreading of cells Increases phenotype PMID:27145024
GO:0045931 Positive regulation of mitotic cell cycle Increases phenotype PMID:35307500
GO:0046087 Cytidine metabolic process Increases phenotype PMID:30487447
GO:0046108 Uridine metabolic process Increases phenotype PMID:30487447
GO:0046621 Negative regulation of organ growth Increases phenotype PMID:30487447
GO:0060326 Cell chemotaxis Increases phenotype PMID:32466334
GO:0070471 Uterine smooth muscle contraction Decreases phenotype PMID:23664861
GO:0072520 Seminiferous tubule development Decreases phenotype PMID:29029336
GO:0097202 Activation of cysteine-type endopeptidase activity Increases phenotype PMID:29029336
GO:0160024 Leydig cell proliferation Affects phenotype PMID:28611354
GO:1903047 Mitotic cell cycle process Affects phenotype PMID:32466334
GO:1990403 Embryonic brain development Decreases phenotype PMID:40347494
GO:2000865 Negative regulation of estradiol secretion Increases phenotype PMID:29029336
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.